Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Interim Management Statement & Directorate Change

3 Nov 2011 07:00

RNS Number : 4005R
Flying Brands Limited
03 November 2011
 



 

Flying Brands Limited

 

Interim Management Statement and Directorate Change

 

 

Flying Brands Limited ("Flying Brands" or the "Group") announces its new banking arrangements and a further property disposal. It also reports its Interim Management Statement for the period 1 July 2011 to 2 November 2011 and announces a change of Group Finance Director.

 

Banking update

 

On 27 October 2011 the Group agreed with Barclays Wealth an extension to its current overdraft facility from £800,000 to £1,475,000. The interest rate on this is 4% above base rate and is secured against the Group's freehold property in Jersey. The arrangement cost for this facility was £30,000. The amount is repayable on demand but the facility will expire during December 2011. 

 

On 2 November 2011, the Group obtained a waiver from Barclays Wealth for the breach of its banking covenants on its treasury loan facility for the quarter ending 30 September 2011. It is intended to repay the balance of this term loan facility amounting to £1.5m out of the proceeds of the proposed property disposals summarised below.

 

Disposal of Meadow Springs Property

 

The Board is pleased to announce that terms have been agreed to sell the Group's glasshouse premises at Meadow Springs (the "Glasshouse") to Jersey Choice Limited ("Jersey Choice") which trades as Jersey Plants Direct. The Glasshouse has a current book value of £1.15m and is used during the Spring gardening season to grow bedding plants. Following the sale of the Glasshouse the Group will retain all its growing and dispatch operation at Retreat Farm, Jersey.

 

The consideration agreed is £1.225m to be satisfied in cash at completion.

 

The sale of the Glasshouse will reduce the Group's overheads by £0.2m per annum. The Group will reorganise its remaining growing operation to maximise capacity. However, as a result of the sale, some bedding plants may be purchased from third party suppliers. It is anticipated that this would lead to an increase in the cost of sales in 2011 by £0.15m.

 

There will be a small profit on the disposal of the Meadow Springs Property of £0.04m as the consideration of £1.225m less the cost of disposal of £0.04m will be in excess of the book value of the Meadow Springs Property which at 30 June 2011 was £1.17m.

 

The purchase agreement is conditional upon completion of normal Jersey conveyancing formalities and upon completion of the purchaser's funding arrangements.

The sale is a Class 1 transaction and is therefore subject to shareholder approval under the UKLA Listing Rules.

 

Disposal of Retreat Farm Property

 

The Group also announced on 26 September that terms have been agreed to sell a part of its premises at Retreat Farm (the "Property") to J.A.J. Properties Limited ("J.A.J. Properties") a Jersey-based property developer. The Property has a current book value of £0.4m and consists of unutilised office space and employee accommodation which do not generate any profit for the Company. The Property is surplus to the requirements of the Company and incidental to the activities of the business and the proposed sale will not in any way affect the Group's growing and dispatch operation that is carried out from nearby but separate properties.

 

The consideration agreed is £2.1m to be satisfied in cash at completion plus 10% of any eventual development profits. 

 

The purchase agreement is conditional upon completion of normal Jersey conveyancing formalities but is not conditional upon receipt of planning permission for development of the Property. J.A.J. Properties has paid a deposit of £500,000 that is refundable only in the event of the conditions not being satisfied.

 

A circular detailing the property transactions and a notice of an extraordinary general meeting will be sent to shareholders in due course with the aim of completing the sales in November 2011.

 

Trading

 

Overall Group sales, for the three months ended 30 September 2011 including discontinued business were £4.6m (2010: £6.0m).

 

Q3 2011 Q3 2010

£m £m

Garden Division

Bedding plants 1.5 2.2

Bird seed 0.6 0.8

Hardware 0.4 0.1

2.5 3.1

 

Gifts Division

Direct to consumer 1.6 1.9

Other 0.1 0.1

1.7 2.0

 

Entertainment Division 0.3 0.4

Total on-going business 4.5 5.5

 

Discontinued operations 0.1 0.5

Total Group sales 4.6 6.0

 

Garden Division

The Group experienced difficult trading conditions in our core bedding plants business in the Autumn season. The Autumn marketing campaign was more closely targeted towards Autumn ordering customers than in previous years. However, the cool summer weather resulted in demand for Autumn bedding plants being suppressed. Margins were affected by the need to sell products at a discount earlier than planned to stimulate sales and ensure that stock surpluses were minimised.

 

The bird seed business performed ahead of management expectations. This market remains highly competitive and with increasing raw material prices has seen margins tighten during the period. 

 

After a satisfactory performance in the first half of the year, Garden Centre Online saw weaker demand. As with the bedding plant business, the cool summer resulted in lower demand and increasing pressure on margins as competitors discounted product to clear ranges for the next season.

 

Gifts Division

The Group's direct-to-consumer business continues to be affected by weak consumer spending. In response to this the management team has focussed on quality, value for money products and improving efficiency.

 

The business continues to develop a number of partnerships with other retailers that operate in similar consumer markets or sell complementary products. These partnerships are in the early stage of development but are likely to deliver additional revenues in the next 12 months.

 

As stated in the trading update issued on 23 September, trading in the three months to 30 September was significantly below management expectations.

 

Financial Position

 

At 30 September the Group had an overdraft of £0.3m (2010: gross cash of £2.8m). The net debt position at 30 September was £2.0m compared to £0.2m in 2010.

 

Directorate change

 

Flying Brands Limited has accepted the resignation of Anthony Gee as Group Finance Director and Company Secretary. Anthony is resigning for personal reasons.

 

Stuart Dootson will be appointed to the Board as an Executive Director with immediate effect and will act as Group Finance Director and Company Secretary. Anthony will continue to work in the business for a period to ensure a smooth handover of duties.

 

Mr Dootson was an executive director of Carbo Plc from November 2002 until it went into administration in March 2005. No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Group Finance Director

 

Smithfield Consultants 020 7360 4900

John Kiely

 

Notes to editors

 

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand and multi channel home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions: 

 

·; Gifts (Flying Flowers, Flowers Direct and Drake Algar  making the company one of the UK'sleading florists)

·; Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Garden Centre Online an internet retailer of garden hardware products)

·; Entertainment (Listen2, a mail order audio books, nostalgic music, DVD and video home shopping retailer)

More information can be found at: www.flyingbrands.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCBDBXGGBGBD
Date   Source Headline
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.